Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday

Share this content:
Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday
Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday

FRIDAY, May 11, 2018 (HealthDay News) -- For patients with osteopenia or osteoporosis, taking a bisphosphonate (BP) drug holiday is associated with increased risk of fracture for patients with lower femoral neck bone mineral density (BMD) or T scores, according to a recent study published in Endocrine Practice.

Brittany Bindon, M.D., from the University of Chicago, and colleagues conducted a retrospective chart review of 401 patients with osteopenia or osteoporosis who began a BP drug holiday from 2004 to 2013.

The researchers found that 15.4 percent of the patients developed a fracture during follow-up. Yearly fracture incidence varied from 3.7 to 9.9 percent, peaking during years four and five at 9.9 and 9.8 percent, respectively. The fracture group had a higher age than the non-fracture group, although the difference was not significant (69.24 ± 12.26 years versus 66.42 ± 10.18 years; P = 0.09). At baseline, the fracture group had lower femoral neck BMD (0.75 ± 0.12 g/cm² versus 0.79 ± 0.10 g/cm²; P = 0.03) and T scores (−2.13 ± 0.99 versus −1.78 ± 0.79; P = 0.01) than the non-fracture group.

"Patients who begin BP drug holidays at high risk of fracture based on BMD, age, or other clinical risk factors warrant close follow-up, especially as its duration lengthens," the authors write. "Fracture risk analysis needs to be regularly assessed during the drug holiday and treatment resumed accordingly."

One author disclosed financial ties to Amgen.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »